Trial Profile
A Real-World Medisoft Audit of ILUVIEN® Treatment in patients with chronic diabetic macular edema (DME)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2017
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 02 Aug 2017 New trial record
- 25 Jul 2017 Results (n=305 patients, 345 eyes) published in the Alimera Sciences Media Release
- 18 Jul 2017 According to an Alimera Sciences media release, data (n=305 patients, 345 eyes) from an ongoing audit of real-world U.K. clinical practice, published online in Eye.